List view / Grid view
Gene Therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.
2 July 2015 | By Victoria White
Biogen and AGTC have announced a broad collaboration and license agreement to develop gene therapies for multiple ophthalmic diseases...
30 June 2015 | By Victoria White
Celgene and Juno Therapeutics have entered into a global collaboration for the development and commercialisation of immunotherapies...
26 June 2015 | By Victoria White
Neuralstem has presented preclinical data on genetically modified HK532-IGF-1 stem cells in Alzheimer's disease at the ISSCR Annual Meeting...
10 June 2015 | By Victoria White
Lycera has formed of an exclusive global collaboration with Celgene to take forward Lycera's proprietary pipeline for cancer and immune-mediated diseases...
9 June 2015 | By Victoria White
Fibrocell and Intrexon have announced positive preclinical data for FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa...
4 June 2015 | By Victoria White
The existing global collaboration between Celgene and bluebird bio has been amended and restated to focus on developing product candidates targeting BCMA...
3 June 2015 | By Victoria White
Inovio has said it will advance its DNA vaccine for MERS into a Phase I clinical trial in healthy volunteers in a collaboration with GeneOne Life Science...
21 May 2015 | By Victoria White
Researchers have identified three genes that play a pivotal role in choroid plexus carcinoma, a discovery that could lead to more effective treatment...
13 May 2015 | By Victoria White
Genethon and Selecta Biosciences have announced an ongoing research collaboration with the goal of enabling repeat dosing for gene therapies...
12 May 2015 | By Victoria White
Mainz-based researchers have made significant advances with regard to the development of individualised cancer immunotherapy strategies...
12 May 2015 | By Victoria White
BioNTech and Lilly are to collaborate to identify and validate novel tumour targets and their corresponding TCRs in one or more types of cancer...
6 May 2015 | By Victoria White
Dicerna Pharmaceuticals has presented positive preclinical data on its proprietary DsiRNA-EX Conjugate-mediated delivery technology at TIDES 2015...
27 April 2015 | By Victoria White
4DMT and Roche are to collaborate to discover and develop optimised next-generation AAV vectors for indications with high unmet medical need...
24 April 2015 | By Victoria White
AstraZeneca and Celgene collaborate for the development and commercialisation of MEDI4736 across a range of blood cancers, including non-Hodgkin’s lymphoma...
23 April 2015 | By Victoria White
Cytori Therapeutics presented data from two preclinical studies at ABA2015. The findings provide greater detail on Cytori's cell therapies...
